Dr. Mark G. Lebwohl Medical Dermatology Fellowship
Zelma Chiesa Fuxench, M.D., of the University of Pennsylvania, received the National Psoriasis Foundation inaugural Dr. Mark G. Lebwohl Medical Dermatology Fellowship, recognizing her work as a promising psoriasis and psoriatic arthritis researcher.
Dr. Chiesa, a third-year dermatology resident, will use the one-year, $40,000 grant to investigate the treatments and associated health risks of psoriasis. Her fellowship also pairs her with Dr. Joel Gelfand, an established UPenn psoriatic disease investigator and epidemiologist, to oversee her work.
Through the fellowship, Chiesa will attempt to:
- Identify the characteristics among patients and their treatments that will allow physicians to predict the likelihood of skin clearance on tumor necrosis factor-alpha (TNF-alpha) inhibitors and methotrexate;
- Determine the risk of major cardiovascular events in people with psoriasis;
- Decide whether treating psoriasis with systemic TNF-alpha inhibitors improves whole-body inflammation associated with psoriasis and lowers risk for cardiovascular disease.
Chiesa's grant honors Dr. Mark Lebwohl—dermatology chair at the Icahn School of Medicine at Mount Sinai—one of the world's foremost psoriasis experts and a leader in medical dermatology.
This year's fellowship was supported by a grant from AbbVie.